Skip to content

Treatment of diabetic neuropathy

A study of comparison of pregabalin, carbamazepine and venlafaxine efficacy to relief painful diabetic neuropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201302188323N6
Enrollment
240
Registered
2013-04-06
Start date
2013-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic neuropathy. Polyneuropathies and other disorders of the peripheral nervous system

Interventions

Intervention 1: Tab venlafaxine 75 mg twice a day for 1 month. Intervention 2: Cap Pregabaline 150mg daily for 1 month. Intervention 3: Tab Carbamazepine 200mg twice a day for a month.
Treatment - Drugs
Tab venlafaxine 75 mg twice a day for 1 month
Cap Pregabaline 150mg daily for 1 month
Tab Carbamazepine 200mg twice a day for a month

Sponsors

Kermanshah Univesity Of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion critreia (Diabetic neuropathy (san antonio critria); Satisfacation ;Not using effective drugs in diabetic neuropathy; No history from seizure; VAS more than 40mm; No history from renal and liver disease , GBS and anemia) Exclusion criteria (Any abnormality in lab test and vital signs; Use antipsychotic drugs or electrical shoch in 30 days ago; Use antidepressant drugs in 14 days ago; Use caspian and lidocain in 7 days ago; Pregnancy and lactation)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain due to diabetic neuropathy. Timepoint: first day , 30th day. Method of measurement: PPI , VAS.

Secondary

MeasureTime frame
Changes in sleep and mood. Timepoint: first day , 30th day. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRazazian Nazanin MD

Kermanshah University Of Medical Science

nrazazian@gmail.com+98 83 1427 6310

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026